Espoo, Finland

Eva Saukko

This inventor holds 2 USPTO granted patents. Top assignee: Orion Corporation. Active years: 2004-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eva Saukko. Retrieved from https://idiyas.com/inventor/eva-saukko

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2004-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Eva Saukko: Innovator in Pharmaceutical Solutions

Introduction

Eva Saukko is a prominent inventor based in Espoo, Finland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of solutions for intravenous administration. With a total of 2 patents, her work focuses on enhancing the stability and efficacy of pharmaceutical solutions.

Latest Patents

Eva's latest patents include innovative formulations of levosimendan, a drug used in the treatment of congestive heart failure. These solutions are designed for pharmaceutical use, specifically for intravenous administration. The inventions boast enhanced stability, making them particularly useful as infusion or injection solutions or infusion concentrates. This advancement is crucial for improving patient outcomes in heart failure treatment.

Career Highlights

Throughout her career, Eva has been associated with Orion Corporation, where she has played a vital role in pharmaceutical research and development. Her expertise in formulating stable pharmaceutical solutions has positioned her as a key figure in her field.

Collaborations

Eva has collaborated with notable colleagues, including Ritva Haikala and Sirpa Pelttari. These partnerships have contributed to the success of her projects and the advancement of pharmaceutical innovations.

Conclusion

Eva Saukko's contributions to pharmaceutical solutions exemplify her dedication to improving healthcare through innovation. Her work continues to impact the treatment of congestive heart failure positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…